Nuclear factor of activated T-cells (NFAT) plays a role in SV40 infection

Virology

Volumn 372, Issue 1, 2008, Pages 48-55

  Manley, Kate ^a   O'Hara, Bethany A ^b   Atwood, Walter J ^b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

JC virus; NFAT; Nuclear factor of activated T cells; Simian virus 40

Indexed keywords

TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; HELA CELL; HUMAN; HUMAN CELL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; VERO CELL; VIRUS INFECTION;

ANIMALS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); SIMIAN VIRUS 40; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; VERO CELLS;

JC POLYOMAVIRUS; POLYOMAVIRUS; SIMIAN VIRUS 40;

EID: 38949193541     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.10.029     Document Type: Article

References (22)

1. Aramburu J., Yaffe M.B., Lopez-Rodriguez C., Cantley L.C., Hogan P.G., and Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285 5436 (1999) 2129-2133
2. Benoist C., and Chambon P. In vivo sequence requirements of the SV40 early promotor region. Nature 290 5804 (1981) 304-310
3. Brizuela L., Ulug E.T., Jones M.A., and Courtneidge S.A. Induction of interleukin-2 transcription by the hamster polyomavirus middle T antigen: a role for Fyn in T cell signal transduction. Eur. J. Immunol. 25 2 (1995) 385-393
4. Butel J.S., and Lednicky J.A. Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl. Cancer Inst. 91 2 (1999) 119-134
5. Diamandopoulos G.T. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 176 31 (1972) 173-175
6. Espel E., Fromental C., Reichenbach P., and Nabholz M. Activity and interleukin 1 responsiveness of SV40 enhancer motifs in a rodent immature T cell line. EMBO J. 9 3 (1990) 929-937
7. Everett R.D., Baty D., and Chambon P. The repeated GC-rich motifs upstream from the TATA box are important elements of the SV40 early promoter. Nucleic Acids Res. 11 8 (1983) 2447-2464
8. Fromm M., and Berg P. Deletion mapping of DNA regions required for SV40 early region promoter function in vivo. J. Mol. Appl. Genet. 1 5 (1982) 457-481
9. Kennedy A.P., Sekulic A., Irvin B.J., Nilson A.E., Dilworth S.M., and Abraham R.T. Polyomavirus middle T antigen as a probe for T cell antigen receptor-coupled signaling pathways. J. Biol. Chem. 273 19 (1998) 11505-11513
10. Lattion A.L., Espel E., Reichenbach P., Fromental C., Bucher P., Israel A., Baeuerle P., Rice N.R., and Nabholz M. Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element. Mol. Cell. Biol. 12 11 (1992) 5217-5227
11. Liu C.K., and Atwood W.J. Propagation and assay of the JC virus. Methods Mol. Biol. 165 (2001) 9-17
12. Macchi M., Bornert J.M., Davidson I., Kanno M., Rosales R., Vigneron M., Xiao J.H., Fromental C., and Chambon P. The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines. EMBO J. 8 13 (1989) 4215-4227
13. Manley K., O'Hara B A., Gee G.V., Simkevich C.P., Sedivy J.M., and Atwood W.J. NFAT4 is required for JC virus infection of glial cells. J. Virol. 80 24 (2006) 12079-12085
14. Mermod N., Williams T.J., and Tjian R. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332 6164 (1988) 557-561
15. Pass H.I., Donington J.S., Wu P., Rizzo P., Nishimura M., Kennedy R., and Carbone M. Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. J. Thorac. Cardiovasc. Surg. 116 5 (1998) 854-859
16. Rollison D.E., and Shah K. The epidemiology of SV40 infection due to contaminated polio vaccines: relation of the virus to human cancer. In: Khalili K., and Stoner G.L. (Eds). Human Polyomaviruses: Molecular and Clinical Perspectives (2001), Wiley-Liss Inc. 561-584
17. Shah K., and Nathanson N. Human exposure to SV40: review and comment. Am. J. Epidemiol. 103 1 (1976) 1-12
18. Stratton K., Almario D.A., and McCormick M.C. SV40 Contamination of Polio Vaccine and Cancer. Immunization Safety Review Committee, Board of Health Promotion and Disease Prevention, Institute of Medicine of the National Academies (2002), The National Academies Press
19. Tjian R. The biochemistry of transcription and gene regulation. Harvey Lect. 90 (1994) 19-39
20. Vilchez R.A., Kozinetz C.A., Arrington A.S., Madden C.R., and Butel J.S. Simian virus 40 in human cancers. Am. J. Med. 114 8 (2003) 675-684
21. Vilchez R.A., Kozinetz C.A., and Butel J.S. Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol. 4 3 (2003) 188-191
22. Zalvide J., and DeCaprio J.A. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15 10 (1995) 5800-5810